• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牙周疾病药物治疗的范式转变。

Paradigm shift in the pharmacological management of periodontal diseases.

作者信息

Hasturk Hatice, Kantarci Alpdogan, Van Dyke Thomas E

机构信息

Department of Periodontology, The Forsyth Institute, Cambridge, MA, USA.

出版信息

Front Oral Biol. 2012;15:160-76. doi: 10.1159/000329678. Epub 2011 Nov 11.

DOI:10.1159/000329678
PMID:22142963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4522924/
Abstract

It is becoming clear that variations in inflammatory response are a major determinant in susceptibility to periodontitis. However, our understanding of the relationship of the causal agents in periodontitis to the pathogenesis is not as clear as we once thought, and thus therapies based on etiopathogenesis are similarly in question. We are entering a new era of therapeutic discovery that may have a major impact on our management of the periodontal diseases. Fundamentally, periodontitis is an irreversible condition and once both soft and hard tissues are lost, the healthy periodontal architecture cannot be completely or predictably rebuilt. The discovery of new families of lipid mediators of resolution of inflammation (the lipoxins) and eicosapentaenoic-acid- and docosahexaenoic-acid-derived chemical mediators (the resolvins and protectins) opens new avenues to designing resolution-targeted therapies to control the unwanted side effects of excessive inflammation. The novel protective and therapeutic actions of pro-resolution lipid mediators following microbial challenge are mediated by regulation of the local and systemic inflammatory response that has a direct impact on the organization of the biofilm (plaque) and suggests a new paradigm in clinical periodontal therapeutics.

摘要

越来越明显的是,炎症反应的差异是易患牙周炎的一个主要决定因素。然而,我们对牙周炎致病因素与发病机制之间关系的理解并不像我们曾经认为的那样清晰,因此基于病因发病机制的治疗方法同样受到质疑。我们正在进入一个治疗发现的新时代,这可能会对我们对牙周疾病的管理产生重大影响。从根本上说,牙周炎是一种不可逆的病症,一旦软硬组织丧失,健康的牙周结构就无法完全或可预测地重建。炎症消退的脂质介质新家族(脂氧素)以及二十碳五烯酸和二十二碳六烯酸衍生的化学介质(消退素和保护素)的发现,为设计以消退为目标的疗法开辟了新途径,以控制过度炎症的不良副作用。微生物攻击后促消退脂质介质的新型保护和治疗作用是通过调节局部和全身炎症反应介导的,这对生物膜(菌斑)的组织有直接影响,并提示了临床牙周治疗的新范式。

相似文献

1
Paradigm shift in the pharmacological management of periodontal diseases.牙周疾病药物治疗的范式转变。
Front Oral Biol. 2012;15:160-76. doi: 10.1159/000329678. Epub 2011 Nov 11.
2
Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation.促消退介质与受体:增强抗牙周炎药物储备的新型药物靶点。
Infect Disord Drug Targets. 2013 Feb;13(1):75-84. doi: 10.2174/18715265112129990034.
3
The management of inflammation in periodontal disease.牙周病炎症的管理
J Periodontol. 2008 Aug;79(8 Suppl):1601-8. doi: 10.1902/jop.2008.080173.
4
Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases.炎症的消退:牙周疾病发病机制的新范式。
J Dent Res. 2003 Feb;82(2):82-90. doi: 10.1177/154405910308200202.
5
Natural resolution of inflammation.炎症的自然消退
Periodontol 2000. 2013 Oct;63(1):149-64. doi: 10.1111/prd.12034.
6
Host-mediated resolution of inflammation in periodontal diseases.宿主介导的牙周疾病炎症消退
Periodontol 2000. 2006;40:144-63. doi: 10.1111/j.1600-0757.2005.00145.x.
7
Lipoxins and new lipid mediators in the resolution of inflammation.脂氧素与炎症消退中的新型脂质介质
Curr Opin Pharmacol. 2006 Aug;6(4):414-20. doi: 10.1016/j.coph.2006.02.006. Epub 2006 Jun 5.
8
Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.动脉粥样硬化、牙周病与 resolvins 的治疗。
Curr Atheroscler Rep. 2017 Nov 6;19(12):57. doi: 10.1007/s11883-017-0696-4.
9
Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.使用抗蛋白酶、抗炎和保骨剂进行牙周宿主调节:一项系统评价。
Ann Periodontol. 2003 Dec;8(1):12-37. doi: 10.1902/annals.2003.8.1.12.
10
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.急性炎症的消退机制:消退过程中新型促消退脂质介质
Semin Immunol. 2015 May;27(3):200-15. doi: 10.1016/j.smim.2015.03.004. Epub 2015 Apr 7.

引用本文的文献

1
Resolvin E1 and calvarial defects in rats: a comprehensive histological analysis.消退素E1与大鼠颅骨缺损:一项全面的组织学分析
Saudi Dent J. 2025 Apr 14;37(1-3):2. doi: 10.1007/s44445-025-00003-4.
2
Engineered Tissue Models to Decode Host-Microbiota Interactions.用于解码宿主-微生物群相互作用的工程组织模型
Adv Sci (Weinh). 2025 Jun;12(23):e2417687. doi: 10.1002/advs.202417687. Epub 2025 May 14.
3
The prohibitin ligand IN44 decreases Porphyromonas gingivalis mediated inflammation.抑制素配体IN44可减轻牙龈卟啉单胞菌介导的炎症。

本文引用的文献

1
Professor Miller's "Micro-Organisms of the Human Mouth".米勒教授的《人类口腔中的微生物》。
Int Dent J (Phila). 1890 Dec;11(12):789.
2
Host Responses in Periodontal Diseases: Current Concepts.牙周疾病中的宿主反应:当前概念
J Periodontol. 1992 Apr;63 Suppl 4S:338-355. doi: 10.1902/jop.1992.63.4s.338.
3
Dental plaque biofilms: communities, conflict and control.牙菌斑生物膜:群落、冲突与控制
BMC Oral Health. 2024 Dec 21;24(1):1534. doi: 10.1186/s12903-024-05209-2.
4
Relationship between Carotid Intima-Media Thickness, Periodontal Disease, and Systemic Inflammation Biomarkers in an Adult Population.成年人群中颈动脉内膜中层厚度、牙周病与全身炎症生物标志物之间的关系。
Biomedicines. 2024 Jun 27;12(7):1425. doi: 10.3390/biomedicines12071425.
5
Resolvins as a Treatment Modality in Experimental Periodontitis: A Systematic Review of Preclinical Studies.消退素作为实验性牙周炎治疗方式的系统评价:临床前研究综述
Cureus. 2022 Jan 10;14(1):e21095. doi: 10.7759/cureus.21095. eCollection 2022 Jan.
6
Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammation.AMY-101 治疗牙周炎成人患者的 IIa 期临床试验。
J Clin Invest. 2021 Dec 1;131(23). doi: 10.1172/JCI152973.
7
Selective Antimicrobial Therapies for Periodontitis: Win the "Battle and the War".牙周炎的选择性抗菌治疗:赢得“战役和战争”。
Int J Mol Sci. 2021 Jun 16;22(12):6459. doi: 10.3390/ijms22126459.
8
Characterization of an ester-based core-multishell (CMS) nanocarrier for the topical application at the oral mucosa.用于口腔黏膜局部应用的基于酯的核-多壳(CMS)纳米载体的特性研究。
Clin Oral Investig. 2021 Oct;25(10):5795-5805. doi: 10.1007/s00784-021-03884-x. Epub 2021 Apr 5.
9
Application of specialized pro-resolving mediators in periodontitis and peri-implantitis: a review.专性促炎消退介质在牙周炎和种植体周围炎中的应用:综述。
Eur J Oral Sci. 2021 Feb;129(1):e12759. doi: 10.1111/eos.12759. Epub 2021 Feb 9.
10
Nutrition as a Key Modifiable Factor for Periodontitis and Main Chronic Diseases.营养作为牙周炎和主要慢性疾病的关键可改变因素。
J Clin Med. 2021 Jan 7;10(2):197. doi: 10.3390/jcm10020197.
Periodontol 2000. 2011 Feb;55(1):16-35. doi: 10.1111/j.1600-0757.2009.00339.x.
4
[Pro-resolving lipid mediators in inflammatory lung diseases].[炎症性肺部疾病中的促消退脂质介质]
Pneumologie. 2011 Mar;65(3):149-58. doi: 10.1055/s-0030-1255913. Epub 2010 Nov 29.
5
Why should a doctor be interested in oral disease?医生为什么应该关注口腔疾病?
Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1483-93. doi: 10.1586/erc.10.109.
6
Clinical challenges in diagnosing and monitoring periodontal inflammation.牙周炎症诊断与监测中的临床挑战
J Calif Dent Assoc. 2010 Apr;38(4):263-70.
7
Too old to fight? Aging and its toll on innate immunity.太老了无法战斗?衰老及其对固有免疫的影响。
Mol Oral Microbiol. 2010 Feb;25(1):25-37. doi: 10.1111/j.2041-1014.2009.00562.x.
8
Discovery and development of penicillin.青霉素的发现与研发。
Dent Rec (London). 1946 Aug;66(8):197-200.
9
Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion.脂氧素 A4 类似物通过减轻炎症反应对大鼠局灶性脑缺血再灌注损伤起保护作用。
Brain Res. 2010 Apr 6;1323:174-83. doi: 10.1016/j.brainres.2010.01.079. Epub 2010 Feb 4.
10
Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases.用于牙周疾病治疗的非手术化疗策略。
Dent Clin North Am. 2010 Jan;54(1):13-33. doi: 10.1016/j.cden.2009.08.010.